Does the media favor DGX or HIMS?

In the previous week, Hims & Hers Health had 27 more articles in the media than Quest Diagnostics. MarketBeat recorded 43 mentions for Hims & Hers Health and 16 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 0.54 beat Hims & Hers Health's score of 0.11 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 4 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 4 Very Positive mention(s) 4 Positive mention(s) 31 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, LH or HIMS?

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Labcorp $13.95B 1.80 $876.50M $12.09 25.59 Hims & Hers Health $2.35B 2.92 $128.37M -$0.63 N/A

Does the media refer more to LH or HIMS?

In the previous week, Hims & Hers Health had 29 more articles in the media than Labcorp. MarketBeat recorded 43 mentions for Hims & Hers Health and 14 mentions for Labcorp. Labcorp's average media sentiment score of 0.43 beat Hims & Hers Health's score of 0.11 indicating that Labcorp is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 4 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 4 Very Positive mention(s) 4 Positive mention(s) 31 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer HIMS or GH?

In the previous week, Hims & Hers Health had 38 more articles in the media than Guardant Health. MarketBeat recorded 43 mentions for Hims & Hers Health and 5 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.43 beat Hims & Hers Health's score of 0.11 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 4 Very Positive mention(s) 4 Positive mention(s) 31 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, HIMS or TEM?

Hims & Hers Health has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 2.92 $128.37M -$0.63 N/A Tempus AI $1.27B 11.76 -$245.03M -$1.44 N/A

Does the media prefer HIMS or TEM?

In the previous week, Hims & Hers Health had 6 more articles in the media than Tempus AI. MarketBeat recorded 43 mentions for Hims & Hers Health and 37 mentions for Tempus AI. Tempus AI's average media sentiment score of 0.49 beat Hims & Hers Health's score of 0.11 indicating that Tempus AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 4 Very Positive mention(s) 4 Positive mention(s) 31 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Tempus AI 14 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Hims & Hers Health (HIMS) Competitors

$29.64 +0.37 (+1.25%)

As of 12:09 PM Eastern

Compare

HIMS vs. DGX, LH, GH, TEM, and FMS

Should you buy Hims & Hers Health stock or one of its competitors? Hims & Hers Health's main competitors and comparable companies include Quest Diagnostics (DGX), Labcorp (LH), Guardant Health (GH), Tempus AI (TEM), and Fresenius Medical Care AG & Co. KGaA (FMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hims & Hers Health compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

Quest Diagnostics has a net margin of 9.18% compared to Hims & Hers Health's net margin of -5.51%. Quest Diagnostics' return on equity of 16.01% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.18%	16.01%	7.27%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Quest Diagnostics has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, meaning that its share price is 142% more volatile than the broader market.

Quest Diagnostics currently has a consensus target price of $237.08, suggesting a potential downside of 0.08%. Hims & Hers Health has a consensus target price of $32.43, suggesting a potential upside of 10.23%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

88.1% of Quest Diagnostics shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Quest Diagnostics has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	2.37	$992M	$9.42	25.19
Hims & Hers Health	$2.35B	2.92	$128.37M	-$0.63	N/A

In the previous week, Hims & Hers Health had 27 more articles in the media than Quest Diagnostics. MarketBeat recorded 43 mentions for Hims & Hers Health and 16 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 0.54 beat Hims & Hers Health's score of 0.11 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quest Diagnostics	4 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	4 Very Positive mention(s)	4 Positive mention(s)	31 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Quest Diagnostics beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Labcorp?

Labcorp (NYSE:LH) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Labcorp has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, suggesting that its stock price is 142% more volatile than the broader market.

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.80	$876.50M	$12.09	25.59
Hims & Hers Health	$2.35B	2.92	$128.37M	-$0.63	N/A

Labcorp has a net margin of 6.99% compared to Hims & Hers Health's net margin of -5.51%. Labcorp's return on equity of 16.74% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.99%	16.74%	7.81%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

In the previous week, Hims & Hers Health had 29 more articles in the media than Labcorp. MarketBeat recorded 43 mentions for Hims & Hers Health and 14 mentions for Labcorp. Labcorp's average media sentiment score of 0.43 beat Hims & Hers Health's score of 0.11 indicating that Labcorp is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	4 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	4 Very Positive mention(s)	4 Positive mention(s)	31 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Labcorp presently has a consensus target price of $337.73, suggesting a potential upside of 9.18%. Hims & Hers Health has a consensus target price of $32.43, suggesting a potential upside of 10.23%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

Summary

Labcorp beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Guardant Health?

Hims & Hers Health (NYSE:HIMS) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Hims & Hers Health presently has a consensus price target of $32.43, indicating a potential upside of 10.23%. Guardant Health has a consensus price target of $188.13, indicating a potential upside of 5.57%. Given Hims & Hers Health's higher possible upside, research analysts clearly believe Hims & Hers Health is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

In the previous week, Hims & Hers Health had 38 more articles in the media than Guardant Health. MarketBeat recorded 43 mentions for Hims & Hers Health and 5 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.43 beat Hims & Hers Health's score of 0.11 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	4 Positive mention(s)	31 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hims & Hers Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.92	$128.37M	-$0.63	N/A
Guardant Health	$982.02M	24.35	-$416.28M	-$3.49	N/A

Hims & Hers Health has a beta of 2.42, suggesting that its share price is 142% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market.

Hims & Hers Health has a net margin of -5.51% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Guardant Health	-38.33%	N/A	-25.40%

Summary

Hims & Hers Health beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Tempus AI?

Hims & Hers Health (NYSE:HIMS) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Hims & Hers Health presently has a consensus price target of $32.43, indicating a potential upside of 10.23%. Tempus AI has a consensus price target of $69.63, indicating a potential downside of 16.02%. Given Hims & Hers Health's higher probable upside, equities analysts plainly believe Hims & Hers Health is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Hims & Hers Health has a beta of 2.42, indicating that its share price is 142% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.72, indicating that its share price is 272% more volatile than the broader market.

Hims & Hers Health has a net margin of -5.51% compared to Tempus AI's net margin of -17.77%. Hims & Hers Health's return on equity of -6.51% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Tempus AI	-17.77%	-50.28%	-10.33%

In the previous week, Hims & Hers Health had 6 more articles in the media than Tempus AI. MarketBeat recorded 43 mentions for Hims & Hers Health and 37 mentions for Tempus AI. Tempus AI's average media sentiment score of 0.49 beat Hims & Hers Health's score of 0.11 indicating that Tempus AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	4 Positive mention(s)	31 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tempus AI	14 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hims & Hers Health has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.92	$128.37M	-$0.63	N/A
Tempus AI	$1.27B	11.76	-$245.03M	-$1.44	N/A

Summary

Hims & Hers Health beats Tempus AI on 10 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.92	$128.37M	-$0.63	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.55	$1.11B	$1.93	11.71

In the previous week, Hims & Hers Health had 41 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 43 mentions for Hims & Hers Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.99 beat Hims & Hers Health's score of 0.11 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	4 Positive mention(s)	31 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Hims & Hers Health's net margin of -5.51%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hims & Hers Health has a beta of 2.42, suggesting that its share price is 142% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

Hims & Hers Health currently has a consensus target price of $32.43, suggesting a potential upside of 10.23%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, suggesting a potential upside of 4.30%. Given Hims & Hers Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Hims & Hers Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Summary

Hims & Hers Health and Fresenius Medical Care AG & Co. KGaA tied by winning 8 of the 16 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$6.86B	$9.69B	$7.24B	$22.83B
Dividend Yield	N/A	2.59%	2.52%	3.61%
P/E Ratio	-46.70	34.80	274.66	27.90
Price / Sales	2.92	5.07	686.13	21.92
Price / Cash	36.36	122.11	77.80	38.70
Price / Book	12.36	5.21	10.45	4.65
Net Income	$128.37M	$315.70M	$3.48B	$1.07B
7 Day Performance	5.07%	1.10%	-1.05%	-1.37%
1 Month Performance	-7.26%	1.07%	-4.36%	-5.48%
1 Year Performance	-46.45%	18.26%	16.36%	7.60%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	2.2536 of 5 stars	$29.65 +1.2%	$32.43 +9.4%	-45.1%	$6.89B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Up
DGX Quest Diagnostics	4.0938 of 5 stars	$235.06 -4.0%	$237.08 +0.9%	+26.6%	$25.94B	$11.04B	24.95	57,000	High Trading Volume
LH Labcorp	4.0389 of 5 stars	$310.63 -3.2%	$337.73 +8.7%	+10.5%	$25.19B	$13.95B	25.69	71,000
GH Guardant Health	1.9752 of 5 stars	$177.11 +1.9%	$188.13 +6.2%	+206.0%	$23.77B	$982.02M	N/A	2,506
TEM Tempus AI	1.6339 of 5 stars	$77.07 -1.2%	$69.63 -9.7%	+3.8%	$13.91B	$1.27B	N/A	3,800	Trending News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 9/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. DGX, LH, GH, TEM, and FMS

How does Hims & Hers Health compare to Quest Diagnostics?

Summary

How does Hims & Hers Health compare to Labcorp?

Summary

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to Tempus AI?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. DGX, LH, GH, TEM, and FMS

How does Hims & Hers Health compare to Quest Diagnostics?

Is DGX or HIMS more profitable?

Which has more volatility and risk, DGX or HIMS?

Do analysts prefer DGX or HIMS?

Do insiders and institutionals hold more shares of DGX or HIMS?

Which has stronger valuation & earnings, DGX or HIMS?

Does the media favor DGX or HIMS?

Summary

How does Hims & Hers Health compare to Labcorp?

Do insiders and institutionals hold more shares of LH or HIMS?

Which has more risk & volatility, LH or HIMS?

Which has better earnings & valuation, LH or HIMS?

Is LH or HIMS more profitable?

Does the media refer more to LH or HIMS?

Do analysts recommend LH or HIMS?

Summary

How does Hims & Hers Health compare to Guardant Health?

Do analysts rate HIMS or GH?

Does the media prefer HIMS or GH?

Do institutionals & insiders have more ownership in HIMS or GH?

Which has higher valuation & earnings, HIMS or GH?

Which has more volatility and risk, HIMS or GH?

Is HIMS or GH more profitable?

Summary

How does Hims & Hers Health compare to Tempus AI?

Do analysts recommend HIMS or TEM?

Do insiders & institutionals have more ownership in HIMS or TEM?

Which has more risk and volatility, HIMS or TEM?

Is HIMS or TEM more profitable?

Does the media prefer HIMS or TEM?

Which has higher earnings and valuation, HIMS or TEM?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has stronger earnings & valuation, HIMS or FMS?

Does the media prefer HIMS or FMS?

Is HIMS or FMS more profitable?

Do insiders & institutionals hold more shares of HIMS or FMS?

Which has more volatility and risk, HIMS or FMS?

Do analysts rate HIMS or FMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools